Latest News and Press Releases
Want to stay updated on the latest news?
-
Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”)Interim Results for the six months ended 31 December 2019 Record level of operating profit pre R&D supported by strong...
-
Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”) Successful litigation settlement relating to PQ Grass Phase II Trial 27 June 2019 Allergy Therapeutics plc (AIM: AGY), the...
-
Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading Update and Successful Litigation Settlement 2019 full year earnings expected to be ahead of market expectations 27 June...
-
Allergy Therapeutics plc(“Allergy Therapeutics” or the “Group”) Trading update Group’s market share continues to grow 12 July 2018 Allergy Therapeutics plc (AIM: AGY), the fully integrated...